151.95  -0.31 (-0.2%)		10-27 16:00
Open: 152.03 High: 152.7 Volume: 681,782		Pre. Close: 152.26 Low: 150.77 Market Cap: 10,795(M)

Short term
Mid term
Targets	6-month :	182.13	1-year :	212.73
Resists	First :	155.94	Second :	182.13
Pivot price	147.58
Supports	First :	144.88	Second :	138.05
MAs	MA(5) :	153.11	MA(20) :	146.51
	MA(100) :	163.27	MA(250) :	165.38
MACD	MACD :	0.7	Signal :	-0.8
%K %D	K(14,3) :	83	D(3) :	88.3
RSI	RSI(14): 54.8
52-week	High :	200.44	Low :	130.22

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ ALGN ] has closed below upper band by 28.4%. Bollinger Bands are 12.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	153.03 - 153.95	153.95 - 154.63
Low:	148.55 - 149.78	149.78 - 150.7
Close:	150.33 - 152.15	152.15 - 153.5

Align Technology, Inc. is a medical technology enterprise that develops, produces, and markets its leading products: Invisalign transparent dental aligners and iTero digital intraoral scanners, along with related services. These offerings serve a wide range of dental professionals, including orthodontists, general dentists, and those specializing in restorative and cosmetic dentistry. The company's operations are divided into two main business units: "Clear Aligner" and "Scanners and Services." The Clear Aligner segment offers a variety of solutions. Its comprehensive products include the full Invisalign treatment for teenage patients, designed to address complex orthodontic needs such as mandibular advancement, patient compliance tracking, and managing tooth eruption. It also features specialized Invisalign First Phase I and Phase 2 packages for younger children, typically aged seven to ten, who have mixed dentition (a combination of primary and permanent teeth). Beyond these, the segment provides non-comprehensive aligner options like Invisalign moderate, lite, express, and Invisalign Go. Additional non-case products include retention devices, fees for Invisalign training, and sales of ancillary items such as cleaning materials and adjustment tools used by dental practitioners during treatment. The Scanners and Services segment centers around the iTero scanner, a unified hardware platform offering various software applications for both restorative and orthodontic procedures. It supplies specialized restorative software to general dentists, prosthodontists, periodontists, and oral surgeons, as well as distinct software for orthodontists to manage digital patient records, perform diagnoses, and facilitate the fabrication of printed models and retainers. This segment also provides computer-aided design and manufacturing (CAD/CAM) services, along with supplementary products like disposable covers for the scanner wand and iTero models and dies. Furthermore, it includes third-party scanners and digital scan solutions, the Invisalign Outcome Simulator (a chair-side and cloud-based application for the iTero scanner), the Invisalign Progress Assessment tool, and TimeLapse technology, which enables clinicians to compare a patient's historical 3D scans against current data. Align Technology distributes its products worldwide, with a strong presence in the United States, Switzerland, and China. Founded in 1997, the company is headquartered in Tempe, Arizona.

Tue, 27 Oct 2026
Is the Options Market Predicting a Spike in Align Technology Stock? - Zacks Investment Research

Tue, 27 Oct 2026
What to expect from Align Technology’s (ALGN) Q3 earnings - Yahoo Finance

Mon, 26 Oct 2026
Align Technology Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mon, 26 Oct 2026
Align Technology Pledges $1 Million to AAO Foundation - Dentistry Today

Mon, 26 Oct 2026
A $1 million pledge will help fund fellowships for orthodontic teachers. - Stock Titan

Sun, 25 Oct 2026
Invisalign’s Moment of Truth: Will International Growth Save ALGN on Oct 28? - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Outperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	71 (M)
Shares Float	67 (M)
Held by Insiders	6.1 (%)
Held by Institutions	105.3 (%)
Shares Short	4,200 (K)
Shares Short P.Month	3,860 (K)

EPS	5.75
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	59.4
Profit Margin	9.9 %
Operating Margin	18.2 %
Return on Assets (ttm)	7.5 %
Return on Equity (ttm)	10.1 %
Qtrly Rev. Growth	4.3 %
Gross Profit (p.s.)	41.24
Sales Per Share	58.27
EBITDA (p.s.)	13.03
Qtrly Earnings Growth	-12.2 %
Operating Cash Flow	756 (M)
Levered Free Cash Flow	594 (M)

PE Ratio	26.42
PEG Ratio	0.6
Price to Book value	2.55
Price to Sales	2.6
Price to Cash Flow	14.28

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.